Flash 2: Management of Metastatic Disease
Moderator:
Moderator:
Dr. Piya Kiatisevi (Lerdsin Hospital, Thailand),
Dr. Yu-min Lin (Taichung Veterans General Hospital, Taiwan)
Paper Number | Paper Title | Speaker/Moderator | Organization | Country |
---|---|---|---|---|
F2-1 | FACTORS ASSOCIATED WITH DIFFICULT HOME PALLIATIVE CARE AMONG BONE METASTASIS PATIENTS | Dr. Masami Hosaka | Miyagi Cancer Center | Japan |
F2-2 | CANCER MAY ACCELERATE LOCOMOTIVE SYNDROME AND DETERIORATE QUALITY OF LIFE: A SINGLE-CENTRE CROSS-SECTIONAL STUDY OF LOCOMOTIVE SYNDROME IN CANCER PATIENTS | Dr. Masahiro Hirahata | Teikyo University School of Medicine | Japan |
F2-3 | PATHOLOGICAL HUMERUS FRACTURE FROM GASTROINTESTINAL STROMAL TUMOR BONE METASTASIS | Dr. Johnson Pok-Him Tam | Queen Mary Hospital | Hong Kong |
F2-4 | AMBULATION ABILITY CAN AFFECT BOTH PHYSICAL AND MENTAL QOL OF CANCER PATIENTS WITH BONE METASTASES | Dr. Oto Yamamoto | Teikyo Univercity School of Medicine | Japan |
F2-5 | VIDEO ASSITED THORACIC SURGERY (VATS) FOR PULMONARY METASTASIS OF OSTEOSARCOMA – NEW PERSPECTIVE : REPORT THE FIRST 6 CASES VATS REMOVE PULMONARY METASTASIS (PM) OF OSTEOSARCOMA IN VIET NAM | Dr The Hung Le | Orthopaedic and Sport Medicine Center | Vietnam |
F2-6 | COMPARISON OF PATIENTS WITH INCIDENTAL MALIGNANT BONE TUMORS OF RIB WITH SYMPTOMATIC PATIENTS | Mr. Jun Iwatsu | Tohoku University Hospital | Japan |
F2-7 | A NOVEL PREDICTIVE SCORING SYSTEM FOR THERAPEUTIC RESPONSE TO IMMUNE CHECKPOINT INHIBITORS ON BONE METASTASES OF NON-SMALL CELL LUNG CANCER BASED ON EARLY DYNAMICS OF SERUM INFLAMMATORY INDICATORS | Dr. Yohei Asano | Kanazawa University Graduate School of Medical Sciences | Japan |
F2-8 | DOES CONCOMITANT THERAPY WITH IMMUNE CHECKPOINT INHIBITORS AND DENOSUMAB IMPROVE CLINICAL OUTCOMES IN NON-SMALL CELL LUNG CANCER WITH BONE METASTASES? | Dr. Yohei Asano | Kanazawa University Graduate School of Medical Sciences | Japan |
F2-9 | IDENTIFICATION OF INDEPENDENT RISK FACTORS FOR OSTEOPOROTIC VERTEBRAL FRACTURES IN CANCER PATIENTS WITHOUT BONE METASTASIS | Dr. Hirotaka Koyanagi | Saitama Cancer Center | Japan |
F2-10 | SURVIVAL ANALYSIS IN CHOLANGIOCARCINOMA WITH MUSCULOSKELETAL SYSTEM METASTASIS. | Dr. Janista Wongratanacheewin | KhonKaen University | Thailand |
Q&A / Panel Discussion |